Synlogic (SYBX) Competitors $1.74 +0.04 (+2.06%) As of 10/8/2025 03:58 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SYBX vs. VTVT, CRVO, PMVP, UNCY, INCR, BYSI, STRO, RPTX, VNRX, and ATYRShould you be buying Synlogic stock or one of its competitors? The main competitors of Synlogic include vTv Therapeutics (VTVT), CervoMed (CRVO), PMV Pharmaceuticals (PMVP), Unicycive Therapeutics (UNCY), InterCure (INCR), BeyondSpring (BYSI), Sutro Biopharma (STRO), Repare Therapeutics (RPTX), VolitionRx (VNRX), and aTyr Pharma (ATYR). These companies are all part of the "pharmaceutical products" industry. Synlogic vs. Its Competitors vTv Therapeutics CervoMed PMV Pharmaceuticals Unicycive Therapeutics InterCure BeyondSpring Sutro Biopharma Repare Therapeutics VolitionRx aTyr Pharma Synlogic (NASDAQ:SYBX) and vTv Therapeutics (NASDAQ:VTVT) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, valuation, earnings, profitability, media sentiment and analyst recommendations. Which has more risk and volatility, SYBX or VTVT? Synlogic has a beta of 0.55, indicating that its share price is 45% less volatile than the S&P 500. Comparatively, vTv Therapeutics has a beta of 0.67, indicating that its share price is 33% less volatile than the S&P 500. Which has stronger earnings and valuation, SYBX or VTVT? vTv Therapeutics has higher revenue and earnings than Synlogic. Synlogic is trading at a lower price-to-earnings ratio than vTv Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSynlogic$10K2,029.95-$23.36M-$0.08-21.69vTv Therapeutics$1.02M69.02-$18.46M-$3.12-7.07 Do insiders and institutionals believe in SYBX or VTVT? 63.4% of Synlogic shares are owned by institutional investors. Comparatively, 17.5% of vTv Therapeutics shares are owned by institutional investors. 3.0% of Synlogic shares are owned by insiders. Comparatively, 4.2% of vTv Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Do analysts prefer SYBX or VTVT? vTv Therapeutics has a consensus target price of $35.50, indicating a potential upside of 60.85%. Given vTv Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe vTv Therapeutics is more favorable than Synlogic.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Synlogic 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00vTv Therapeutics 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Is SYBX or VTVT more profitable? Synlogic's return on equity of -8.09% beat vTv Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets SynlogicN/A -8.09% -5.50% vTv Therapeutics N/A -179.75%-55.91% Does the media refer more to SYBX or VTVT? In the previous week, Synlogic had 1 more articles in the media than vTv Therapeutics. MarketBeat recorded 2 mentions for Synlogic and 1 mentions for vTv Therapeutics. vTv Therapeutics' average media sentiment score of 0.59 beat Synlogic's score of 0.00 indicating that vTv Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Synlogic 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral vTv Therapeutics 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryvTv Therapeutics beats Synlogic on 9 of the 15 factors compared between the two stocks. Get Synlogic News Delivered to You Automatically Sign up to receive the latest news and ratings for SYBX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SYBX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SYBX vs. The Competition Export to ExcelMetricSynlogicMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$19.89M$3.35B$6.09B$10.54BDividend YieldN/A2.28%5.69%4.71%P/E Ratio-21.6921.5785.5527.60Price / Sales2,029.95271.43537.79201.45Price / CashN/A47.1237.9261.55Price / Book1.5910.1412.996.76Net Income-$23.36M-$52.31M$3.30B$275.88M7 Day Performance3.27%5.14%4.33%2.81%1 Month Performance17.23%14.68%9.48%9.24%1 Year Performance18.84%30.98%84.61%35.42% Synlogic Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SYBXSynlogic0.361 of 5 stars$1.74+2.1%N/A+18.8%$19.89M$10K-21.6980News CoverageAnalyst ForecastVTVTvTv Therapeutics1.6836 of 5 stars$23.56+2.7%$35.50+50.7%+51.6%$75.16M$1.02M-7.559CRVOCervoMed3.7607 of 5 stars$8.05-0.4%$19.29+139.6%-32.6%$74.46M$9.74M-3.084News CoverageAnalyst ForecastShort Interest ↓PMVPPMV Pharmaceuticals2.7059 of 5 stars$1.40-3.8%$5.50+294.3%-4.4%$73.92MN/A-0.8950UNCYUnicycive Therapeutics2.2875 of 5 stars$4.17+0.4%$57.00+1,268.2%+32.5%$73.83MN/A-1.019Analyst ForecastINCRInterCure1.1763 of 5 stars$1.62+3.8%N/A-10.6%$73.82M$238.85M0.00350News CoverageAnalyst ForecastBYSIBeyondSpringN/A$1.83+5.2%N/A-24.2%$73.80M$1.75M0.0080News CoveragePositive NewsAnalyst ForecastGap UpSTROSutro Biopharma4.1094 of 5 stars$0.87-0.7%$4.47+414.0%-75.7%$73.67M$62.04M-0.34240Analyst ForecastGap DownRPTXRepare Therapeutics2.8005 of 5 stars$1.70-2.3%$4.50+164.7%-47.2%$73.03M$53.48M-0.66180News CoverageAnalyst ForecastVNRXVolitionRx2.3151 of 5 stars$0.67+7.2%$3.50+424.0%-16.1%$71.87M$1.32M-1.8680Gap UpHigh Trading VolumeATYRaTyr Pharma2.8313 of 5 stars$0.72-9.2%$23.25+3,120.2%-48.5%$71.63M$230K-0.9153Analyst ForecastHigh Trading Volume Related Companies and Tools Related Companies vTv Therapeutics Competitors CervoMed Competitors PMV Pharmaceuticals Competitors Unicycive Therapeutics Competitors InterCure Competitors BeyondSpring Competitors Sutro Biopharma Competitors Repare Therapeutics Competitors VolitionRx Competitors aTyr Pharma Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SYBX) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Synlogic, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Synlogic With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
